Polarean Imaging (LON:POLX) Shares Down 10% – Should You Sell?

Polarean Imaging plc (LON:POLXGet Free Report)’s stock price fell 10% on Monday . The stock traded as low as GBX 0.09 and last traded at GBX 0.09. 17,688,098 shares traded hands during mid-day trading, an increase of 147% from the average session volume of 7,148,759 shares. The stock had previously closed at GBX 0.10.

Polarean Imaging Price Performance

The company has a market capitalization of £869,063.76, a price-to-earnings ratio of -0.72 and a beta of 0.38. The company has a 50-day moving average price of GBX 0.17 and a 200-day moving average price of GBX 0.70. The company has a debt-to-equity ratio of 2.61, a quick ratio of 9.80 and a current ratio of 4.12.

Polarean Imaging Company Profile

(Get Free Report)

Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease.

Read More

Receive News & Ratings for Polarean Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarean Imaging and related companies with MarketBeat.com's FREE daily email newsletter.